MedTrace Logo

Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients

NCT05441696 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2024-12-27

No results posted yet for this study

Summary

Track changes in non-invasive central venous pressure across hospital stay and relationship with readmission

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

ezCVP measurement

* Measuring device: non-FDA-cleared patient monitor (740E, Zoe Medical, MA, US), which has software to measure ezCVP. * Sensor: an FDA-cleared pulse oximeter sensor for adults (K012891: DS-100A, Nellcor, CA, US). * Cuff: an FDA-cleared NIBP cuff for adults (K080342: YP-713T, YP-714T or TP-715T, Nihon Kohden Corporation, Tokyo, Japan).

Sponsors & Collaborators

  • Nihon Kohden

    lead INDUSTRY

Principal Investigators

  • Masataka Kawana, MD · Stanford University

  • Patricia Nguyen, MD · Veterans Affairs Hospital Palo Alto

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2025-09-30
Completion
2026-09-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05441696 on ClinicalTrials.gov